Mario Gabelli Neuronetics, Inc. Transaction History

Gamco Investors, Inc. Et Al

$9.22 Billion
Q1 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Neuronetics, Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 38,500 shares of STIM stock, worth $69,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,500

Previous 44,500 13.48%

Holding current value

$69,300

Previous $60,000 205.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.68 - $4.8 $16,080 - $28,800	-6,000 Reduced 13.48%	38,500 $183,000
Q3 2023 Nov 08, 2023	SELL	$1.29 - $2.22 $37,410 - $64,380	-29,000 Reduced 39.46%	44,500 $60,000
Q2 2023 Aug 10, 2023	SELL	$2.07 - $2.92 $8,280 - $11,680	-4,000 Reduced 5.16%	73,500 $158,000
Q1 2023 May 12, 2023	BUY	$2.81 - $6.71 $28,100 - $67,100	10,000 Added 14.81%	77,500 $225,000
Q4 2022 Feb 13, 2023	BUY	$3.44 - $6.87 $27,520 - $54,960	8,000 Added 13.45%	67,500 $463,000

Q3 2022 Nov 10, 2022	SELL	$2.35 - $4.66 $12,925 - $25,630	-5,500 Reduced 8.46%	59,500 $189,000
Q2 2022 Aug 12, 2022	SELL	$2.09 - $3.71 $1,045 - $1,855	-500 Reduced 0.76%	65,000 $209,000
Q1 2022 May 13, 2022	SELL	$2.84 - $4.52 $2,840 - $4,520	-1,000 Reduced 1.5%	65,500 $198,000
Q4 2021 Feb 11, 2022	BUY	$3.87 - $6.59 $59,985 - $102,145	15,500 Added 30.39%	66,500 $297,000
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $111,960 - $279,720	18,000 Added 54.55%	51,000 $335,000
Q2 2021 Aug 13, 2021	BUY	$10.15 - $17.25 $162,400 - $276,000	16,000 Added 94.12%	33,000 $529,000
Q1 2021 May 14, 2021	BUY	$10.6 - $21.27 $180,200 - $361,590	17,000 New	17,000 $210,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $48.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account